Our results add ANXA10 to the repertoire of tumor suppressor proteins that are inhibited by Cul4A in cancer, and thus, it suggests Cul4A as a potential drug target for the development of novel therapy for lung cancer in the future. This evidence concerns the gene CUL4A and lung carcinoma.